Results 241 to 250 of about 553,444 (284)

Gut microbiota-derived metabolite trimethylamine N-oxide alters the host epigenome through inhibition of S-adenosylhomocysteine hydrolase. [PDF]

J Biol Chem
Han JH, Rey FE, Denu JM.
europepmc   +1 more source

Cardiovascular effects of trimethylamine N-oxide (TMAO)

, 2022
openaire   +1 more source

Salivary trimethylamine N-oxide: a novel non-invasive marker for periodontal inflammation. [PDF]

Clin Oral Investig
Serdar CC, Guney Z, Balci N, Altingoz SM, Serdar MA, Kurgan S.   +5 more
europepmc   +1 more source

Mechanisms and Intervention Strategies of Trimethylamine N-Oxide in Abdominal Aortic Aneurysm.

Cardiology
Abudureheman D, Janaerbieke S, Song Y, Han S, Yimaer W, Wang H.   +5 more
europepmc   +1 more source

Trimethylamine N-oxide (TMAO) in human health

EXCLI journal, 2021
Due to numerous links between trimethylamine-N-oxide (TMAO) and various disorders and diseases, this topic is very popular and is often taken up by researchers. TMAO is a low molecular weight compound that belongs to the class of amine oxides.
Paulina Gątarek, J. Kałużna-Czaplińska   +1 more
semanticscholar   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Trimethylamine N-Oxide in Aquatic Foods.

Journal of Agricultural and Food Chemistry
Trimethylamine N-oxide (TMAO), a characteristic nonprotein nitrogen compound, is widely present in seafood, which exhibits osmoregulatory effects for marine organisms in vivo and plays an important role in aquaculture and aquatic product preservation ...
Xiaoyue Li, Cheng-Cheng Wang, Teruyoshi Yanagita, Changhu Xue, Tiantian Zhang, Yuming Wang   +5 more
semanticscholar   +3 more sources

Trimethylamine N-Oxide (TMAO), Diet and Cardiovascular Disease

Current Atherosclerosis Reports, 2021
The association between plasma Trimethylamine N-Oxide (TMAO), diet and risk for cardiovascular disease (CVD) is still not fully understood. While epidemiologic research shows a causal relationship between plasma TMAO concentrations and CVD risk, the role of dietary precursors in determining plasma concentrations of TMAO and biomarkers for CVD is ...
M. Thomas, M. Fernández
semanticscholar   +3 more sources

Genetic polymorphism of trimethylamine N-oxidation

Pharmacology & Therapeutics, 1990
Example of a food idiosyncracy, known to represent a pharmacogenetic polymorphism: trimethylaminuria of «fish-odour syndrome». Primary trimethylaminuria must be distinguished from the trimethylaminurias which are non-genetic in origin and which are secondary to other factors such as renal or hepatic disease or overload with trimethylamine ...
R, Ayesh, R L, Smith
openaire   +2 more sources

Trimethylamine-N-oxide Biosynthesis in the Bullfrog

Nature, 1966
THE comparative aspects of the mechanism of oxygenations dependent on molecular oxygen have recently been investigated using the biosynthesis of trimethylamine-N-oxide as a model1. That investigation raised a number of questions beyond the presence of the enzymatic activity in a given organism.
K, Murray, K, Chakraverty, S, Chaykin
openaire   +2 more sources

Trimethylamine N-oxide synthesis: A human variant

Biochemical Medicine, 1972
Abstract A 6-year-old girl exhibiting a variety of clinical symptoms including an apparant inability to metabolize trimethylamine has been shown to possess a defective liver trimethylamine oxidizing system. The defect manifested itself in a Km for trimethylamine which was five times that characteristic of normal enzyme preparation.
T, Higgins, S, Chaykin, K B, Hammond, J R, Humbert   +3 more
openaire   +2 more sources